Stillbirth Risk and Management in Single Umbilical Artery
Pregnancies with single umbilical artery (SUA) carry a nearly 5-fold increased risk of stillbirth (OR 4.80; 95% CI 2.67-8.62), mandating weekly antenatal fetal surveillance beginning at 36 weeks gestation and third-trimester growth ultrasound. 1
Stillbirth Risk Quantification
The stillbirth risk in SUA is substantially elevated compared to normal cord anatomy:
- Isolated SUA increases stillbirth odds by approximately 5-fold (OR 4.80; 95% CI 2.67-8.62) in population-based studies 1, 2, 3
- This elevated risk persists even when no other structural abnormalities are identified 1
- Additional risks include fetal growth restriction, oligohydramnios, placental abruption, cord prolapse, and perinatal mortality 1, 2
Initial Evaluation When SUA is Identified
When SUA is detected on prenatal ultrasound, perform the following assessment:
- Comprehensive anatomic survey with particular attention to cardiovascular and renal systems, as these are the most commonly affected organ systems 1, 3
- Cardiovascular anomalies show odds ratios ranging from 5.9 to 20.3 for various cardiac defects 3, 4
- Renal anomalies demonstrate a 3-fold increased risk, occurring in approximately 16% of isolated SUA cases 3, 4
- If adequate cardiac views are visualized and normal on the anatomy scan, dedicated fetal echocardiography is not routinely required 1, 2
Aneuploidy Risk Assessment
- For isolated SUA (no other structural abnormalities), no additional aneuploidy testing is recommended, regardless of whether previous screening was performed or declined 1, 2
- Isolated SUA carries no increased risk of chromosomal abnormalities 1, 2, 3
- When SUA occurs with other structural abnormalities (non-isolated SUA), aneuploidy risk ranges from 4% to 50% and genetic testing should be offered 1, 3
Antenatal Surveillance Protocol for Isolated SUA
Third-Trimester Growth Monitoring
- Schedule third-trimester ultrasound examination at 32-36 weeks to evaluate fetal growth 1, 2
- Isolated SUA is associated with a 2.1-fold increased risk of fetal growth restriction (adjusted OR 2.1; 95% CI 1.6-2.7) 2, 4
- This growth restriction risk persists even after excluding all fetuses with known anomalies 4
Fetal Surveillance Timing
- Initiate weekly antenatal fetal surveillance (non-stress testing or biophysical profile) beginning at 36 0/7 weeks gestation 1, 2
- This surveillance is warranted specifically due to the nearly 5-fold increased stillbirth risk 1, 2
Management When Fetal Growth Restriction Develops
If growth restriction is diagnosed during surveillance, escalate management according to umbilical artery Doppler findings:
Serial Doppler Assessment
- Perform serial umbilical artery Doppler assessment to monitor for deterioration when FGR is identified 5, 1
- With decreased end-diastolic velocity (flow ratios >95th percentile) or severe FGR (EFW <3rd percentile): weekly umbilical artery Doppler evaluation 5, 1
- With absent end-diastolic velocity: Doppler assessment 2-3 times per week 5, 1
- With reversed end-diastolic velocity: hospitalization, antenatal corticosteroids, and cardiotocography at least 1-2 times daily 5, 1
Cardiotocography Frequency
- Weekly cardiotocography testing after viability for FGR without absent/reversed end-diastolic velocity 5, 1
- Increase frequency when FGR is complicated by absent/reversed end-diastolic velocity or other comorbidities 5, 1
Delivery Timing Recommendations
Delivery timing is dictated by the presence and severity of fetal growth restriction and Doppler findings:
Isolated SUA Without Growth Restriction
- Standard obstetric management for timing of delivery (expectant management to 39-40 weeks) 1
With Fetal Growth Restriction
- EFW 3rd-10th percentile with normal umbilical artery Doppler: Deliver at 38-39 weeks 5, 1
- Decreased diastolic flow without absent/reversed end-diastolic velocity OR severe FGR (EFW <3rd percentile): Deliver at 37 weeks 5, 1
- Absent end-diastolic velocity: Deliver at 33-34 weeks 5, 1
- Reversed end-diastolic velocity: Deliver at 30-32 weeks 5, 1
Mode of Delivery
- Consider cesarean delivery for pregnancies with FGR complicated by absent/reversed end-diastolic velocity based on the complete clinical picture 5, 1
- Antenatal corticosteroids are indicated if delivery is anticipated before 33 6/7 weeks, or between 34 0/7 and 36 6/7 weeks in women at risk of delivery within 7 days 5, 1
- Intrapartum magnesium sulfate for neuroprotection is recommended for pregnancies <32 weeks 5, 1
Postnatal Considerations
- Notify the pediatric care team of the prenatal SUA finding at delivery 1, 2
- Postnatal examination is critical, as structural anomalies are revealed in up to 7% of infants with a prenatal diagnosis of isolated SUA 1, 2
- Cardiac defects represent the most common postnatal anomaly in this population 2
Critical Pitfalls to Avoid
- Do not omit third-trimester growth assessment, as isolated SUA carries a measurable 2.1-fold increase in FGR risk 2, 4
- Do not delay weekly antenatal surveillance after 36 weeks, given the near-5-fold rise in stillbirth risk 1, 2
- Do not order unnecessary genetic testing for isolated SUA, as it carries no increased aneuploidy risk and wastes resources while causing unnecessary anxiety 2
- Do not offer pregnancy termination for isolated SUA, as this is inappropriate for an isolated finding without structural or chromosomal abnormalities 2